Sight Sciences/SGHT

$4.36

-2.46%
-
1D1W1MYTD1YMAX

About Sight Sciences

Sight Sciences, Inc. is an ophthalmic medical device company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates in two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as the SION Surgical Instrument, a bladeless device used in goniotomy. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.

Ticker

SGHT

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Paul Badawi

Employees

250

Headquarters

Menlo park, United States

Sight Sciences Metrics

BasicAdvanced
$215.96M
Market cap
-
P/E ratio
-$1.28
EPS
-
Beta
-
Dividend rate

What the Analysts think about Sight Sciences

Analyst Ratings

Majority rating from 6 analysts.
Hold

Price Targets

Average projection from 4 analysts.
17.66% upside
High $6.00
Low $4.00
$4.36
Current price
$5.13
Average price target

Sight Sciences Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-65% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$20M
-14.53%
Net income
$-13M
-11.56%
Profit margin
-65%
3.47%

Sight Sciences Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.05%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.35
-$0.35
-$0.30
-$0.27
-
Expected
-$0.42
-$0.39
-$0.34
-$0.32
-$0.32
Surprise
-16.07%
-10.75%
-12.13%
-15.05%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Sight Sciences stock

Buy or sell Sight Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing